2m 2m 2m 2m 2m 2m 2m
ProQR Therapeut (PRQR)
NASDAQ
$1.90+$0.005 (+0.26%)
Price as of Jun 23, 2026 7:30 PM EDT- $197.8MMarket Cap
- -6.90%1-Year Change
- BiotechnologyIndustry
ProQR Therapeut (PRQR)
$1.90+$0.005 (+0.26%)
PRQR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.89 | ||
Change | +$0.01 (+0.53%) | ||
Open | $1.81 | ||
High | $1.98 | ||
Low | $1.81 | ||
Previous Close | $1.88 | ||
Volume | 864,617 | ||
30-Day Average Volume | 589,657 | ||
1-Week Change | 24.34% | ||
1-Month Change | 21.15% | ||
1-Year Change | -6.90% | ||
3-Year Change | 14.20% | ||
5-Year Change | -73.23% | ||
Fundamentals | |||
Shares Outstanding | 105.2M | ||
Total Assets | $112.8M | ||
Market Cap | $197.8M | ||
Enterprise Value | $105.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue